Atlas Trials

CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study

Clinical trial NCT07240168 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07240168
Sponsor
Evinature Ltd.
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Ulcerative Colitis (UC)
Start date
2025-09-07
Primary completion
2026-08-20
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.